Introduction
The XPD gene encodes one of the two helicase subunits of the transcription factor II H (TFIIH). TFIIH has a dual function: it is required both for basal transcription by the RNA polymerases I and II (RNAPI and RNAPII), as well as for nucleotide excision repair (NER) (1, 2) . There are two subpathways of NER, both requiring TFIIH: global genome repair and transcription-coupled repair (TCR) (3, 4) . TCR selectively removes DNA lesions from the transcribed strand of DNA, in order to efficiently repair active DNA regions (5) (6) (7) (8) . TCR is dependent on active transcription and the addition of an RNAPII inhibitor (a-amanitin) abolishes TCR in mammalian cells (9) .
Mutations in the XPD gene give rise to three inherited NER deficiency disorders: xeroderma pigmentosum (XP), trichothiodystrophy (TTD) or, more rarely, combined features of XP and Cockayne syndrome (CS) (XP/CS) (4, 10, 11) . Although the mutations causing these disorders are in the same gene, the features of the disorders are quite different. XP patients suffer from a hypersensitivity to ultraviolet (UV) radiation resulting in an increased risk of skin cancer. Only $50% of TTD patients are photosensitive, and this is the portion of TTD patients that are defective in NER. TTD patients are instead affected by neurological abnormalities such as mental retardation and also exhibit brittle hair due to reduced sulphur content. CS is, like XP, linked to UV sensitivity. Other phenotypes associated with the CS disorder are dwarfism, mental retardation, microcephaly and skeletal abnormalities. Unlike XP patients, CS patients do not have a higher skin cancer risk, for a review see ref. 10 . The position of the gene mutation seems to determine whether the symptoms of the patients will correspond to XP, TTD or XP/CS. The mutations leading to XP or XP/CS lie within one of the helicase domains, which could result in a reduced helicase activity. The TTD causing mutations, on the other hand, are found both in the helicase domain and at the C-terminus of the protein, which may reduce the ability of the Xeroderma Pigmentosum group D protein (XPD) protein to bind other proteins in the TFIIH complex, resulting in destabilisation and impaired transcription (12) .
Patients suffering from CS, without having XP symptoms, have a defect in either of the non-essential CSA or CSB genes. Of these patients, the majority are mutated in the CSB gene. Mutations in the CSA or CSB genes result in defective TCR (11) . The Cockayne syndrome B (CSB) protein also appears to be essential for efficient transcription and transcription elongation in at least some CSB cells (13) . Transcription is linked to DNA repair pathways in aspects other than TCR alone. For example, transcription enhances recombination frequencies in all cellular organisms studied, a phenomenon known as transcription-associated recombination (TAR). TAR was first observed in the k phage (14) and further experiments showed that transcription enhanced recombination levels in Escherichia coli (15) . In eukaryotes, TAR was first observed in Saccharomyces cerevisiae, where recombination was shown to increase in RNAPI driven transcription (16) . The first evidence of TAR in mammals was seen in Chinese hamster ovary (CHO) cells, where a reporter system consisting of heteroallelic neomycin genes was used to show that transcription stimulates recombination (17) . Prado et al. (18) showed that transcription increases recombination frequencies as a consequence of a replication fork blockage caused by a collision between the transcription and replication machineries. Another possible cause of increased recombination frequency might be that the open chromatin structure of the transcribed DNA strands can facilitate recombination by allowing easy access to the DNA for DNA damaging agents (19, 20) . Evidence in yeast indicates that DNA-RNA hybrids between the newly synthesised RNA molecule and the DNA template can be formed during transcription. These hybrids could constitute roadblocks to the next elongating RNA polymerase (21) . The mechanisms behind TAR are still not fully investigated, nor are the proteins involved yet identified, for a recent review see ref. 22 . Here, we reveal a novel role of XPD in TAR, showing that the XPD gene product is required for catalysing this pathway. Furthermore, we show that XPDdeficient cells are proficient in homologous recombination (HR) repair of endonuclease-induced double-strand breaks (DSBs) as well as in the repair of thymidine stalled replication forks. We also report TAR impairment in CSB-deficient cells, although this may be due to a general transcription downregulation.
Materials and methods
The TARneo recombination construct Cell lines: the CHO cell lines UV5, deficient in XPD, UV61, deficient in CSB, and AA8, the parental cell line to UV5 and UV61, were used ( Table I ). The cells were stably transfected with a recombination construct, pBI-LMScI (TARneo) and the tet-regulatory plasmid pTetOffzeo ( Figure 1A ). In brief, the TARneo recombination substrate consists of two non-functional neomycin resistance genes. The 3# neo copy contains an inserted cleavage site for the rare-cutting endonuclease I-SceI. This neo copy is controlled by a bidirectional Tet-off promoter that also controls a luciferase gene. This makes it possible to quantitatively measure the level of transcription. The insertion of this cleavage site functions as a stop codon and renders the gene non-functional. The 5# neo copy of the neo gene is truncated and thereby also non-functional. Recombination can be induced either by enhanced transcription after removal of doxycycline (DOX) or after induction of a DSB at the I-SceI site following transient transfection with the pCMV3xnlsI-SceI vector. A functional neomycin resistance gene can be regained following short-tract gene conversion or longtract gene conversion or sister chromatid exchange The recombination construct also contains a hygromycin resistance gene in order to make it possible to select the cells that have integrated the substrate. For a more detailed description, see ref. 26 .
Transfection
Establishment of cells with the TARneo recombination construct The cells were stably transfected simultaneously with the TARneo construct and the pTetOff plasmid (containing the tetracycline-dependent activator) using electroporation. The both plasmids were purified from E.coli. Fifteen micrograms each of plasmid DNA was used for each transfection. The plasmid DNA was diluted in 50 ll dH 2 O and mixed with 7.5 Â 10 6 cells in an electroporation cuvette. The cells were transfected using the voltage 2.5 kV/cm and the capacitance 25 lF. The electroporated cells were aliquoted in the amounts 20, 50 and 100 ll on petri dishes and incubated for 2 days before the appropriate selective agent was added. After the colonies had formed, 30 colonies of varying sizes were picked and transferred to culture plates for further cultivation.
Establishment of cells expressing wild-type XPD, XP, XP/CS or TTD proteins A plasmid containing complementary DNA (cDNA) sequences corresponding to wild-type XPD was kindly obtained from Dr Larry Thompson (27) . As we needed to use a puromycin resistance plasmid, the cDNA was released by enzymatic digestion. The released fragments were subcloned into the puromycin resistance vector pIRESpuro from Clontech, transformed into competent DH5a E.coli cells and subsequently, the plasmids were extracted using a miniprep kit from Qiagen according to the manufacturer's instructions. The plasmids were sequenced and used to transfect the UV5TofZM7 cell line using electroporation as described above. Transfected cells were plated onto Petri dishes and grown in selective medium. Puromycin resistant clones were picked. Transient transfection with pCMV3xnlsI-SceI in order to induce a DSB was performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's manual.
Luciferase assay
In order to screen for clones, a luciferase assay was performed. The clones were trypsinised and counted and 200 000 cells from each clone were incubated with and without DOX for 24 h prior to lysis. After the incubation, the cells were rinsed twice with Dulbecco's phosphate-buffered saline (PBS) without Ca and Mg. All PBS was removed and 500 ll of lysis buffer was added to each well. The plates were shaken for 20 min in order to lyse the cells and the luciferase activity was measured using a luminometer, LKB Wallac 1250 Luminometer.
Cell culture
The cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% foetal bovine serum and 1% PEST (penicillin-streptomycin). To select for the desired clones and to keep the inserted genes in the cells, zeocin and hygromycin were added to the medium. In order to keep the transcription of the recombination substrate off during growth, DOX was also added to the medium. The cells were cultured in an incubator at 37°C with 5% CO 2 .
Recombination assay Cells (1 Â 10 6 ) were plated on four Petri dishes. To two of the dishes, 10 ll (1 mg/ml) of DOX was added. In the case of I-SceI-induced recombination, the cells were transiently transfected using Lipofectamine after 24 h, according to the manufacturer's protocol. After an additional 24 h, the cells were plated on cloning and selection dishes. On the cloning dishes, 500 cells were seeded and on the selection dishes 300 000 cells were seeded. After 24 h, 100 ll of G418 (1 mg/ml) was added. When colonies had formed (after $10 days for cloning and 15 days for selection), the cells were stained, using methylene blue in methanol, and counted.
Immunofluorescence
To score for RAD51 foci, cells were treated with ionising radiation or thymidine or left untreated as a control. Irradiated cells were treated with 10 Gy and left in an incubator for 5 h in order for foci to appear. For the thymidine treatment, the cells were treated with 2 mM of thymidine for 24 h. For RAD51 foci detection, 50 000 cells per slide were seeded onto sterilised cover slides. The next day, the slides were either irradiated or treated with thymidine. After the treatment, the cells were fixed with 3% paraformaldehyde containing 0.1% Triton X-100. The cells were then rinsed with PBS containing 0.1% TX-100 2 Â 10 min. After rinsing, the cells were permeabilised with PBS þ 0.3% TX-100 for 10 min. The cells were then blocked with PBS þ 3% bovine serum albumin (BSA) for 40 min. After blocking, the primary antibody, h92 Santa Cruz anti RAD51 polyclonal rabbit diluted 1:1000 in PBS þ 3% BSA was added and the cells were left at 4°C over night. The next day, the cells were rinsed with PBS containing 0.1% TX-100. After rinsing, the cells were permeabilised with PBS þ 0.3% TX-100 for 10 min. After permeabilisation, the secondary antibody was added, donkey anti-rabbit alexa 555 from Invitrogen, diluted 1:500 in PBS þ 3% BSA. The slides were incubated in the dark for 1 h. After incubation, the cells were rinsed with PBS containing 0.1% TX-100 2 Â 10 min and permeabilised with PBS þ 0.3% TX-100 for 10 min. They were then rinsed with PBS for 5 min and stained with ToPro from Invitrogen for 30 min. After the ToPro staining, the slides were rinsed with PBS for 5 min and mounted with antifade kit and sealed with nail polish. The slides were coded to make scoring impartial. Cells with .10 foci were scored as positive and 200 cells per slide were scored. NER incision assay using alkaline DNA unwinding The alkaline DNA unwinding technique is a method to measure the amount of single-strand breaks (SSBs) in the DNA formed after NER incision. These SSBs are formed by the incision step of the NER process. DNA is separated in weak alkaline solution, and this separation requires an SSB. The more SSBs detected, the higher the NER activity. Thus, this method is a way to measure the amount of incisions and thus the NER activity (28) . Cells radiolabelled with 3H-TdR were incubated with the inhibitors hydroxyurea (2 mM) and cytosine arabinoside (20 lM) in DMEM for 30 min prior to UV exposure to hinder the polymerisation step of NER. The amount of ssDNA was measured by the alkaline DNA unwinding technique as described in ref. 29 .
UVC survival assay
Five hundred cells from each cell line were plated on Petri dishes over night.
The following day, they were treated with varying doses of UVC. The plates were incubated for 14 days in a 5% CO 2 37°C incubator and were then stained with 0.4% methylene blue in methanol and counted.
Results

XPD-defective cells are impaired in TAR
Although XP cells mutated in the XPD gene are NER defective (30, 31) , they still retain normal levels of transcription (31) . As the XPD protein is required for NER, we wanted to investigate whether this protein is also involved in TAR. To test this, we transfected the XPD-defective UV5 and wild-type AA8 cell lines with the previously described recombination construct, pBI-LMscIneo (TARneo), to investigate the effect on TAR (26) . The cells were co-transfected with the Tet-regulatory vector, pTetOffzeo, for control of the inducibility of the bidirectional promoter. Several hyg R and zeo R clones were selected individually and expanded. The level of transcription on the recombination substrate was monitored in each clone using the luciferase gene, which is co-expressed from the same promoter but in the opposite direction ( Figure 1A) . Two clones from each of the cell lines UV5 and AA8, showing an induction of luciferase activity upon DOX removal, were selected ( Figure 1B) . The selected UV5 clones were named UV5Tof ZM7 and UV5TofZM8 and the AA8 clones were named AA8Tof ZM7 and AA8TofZM16. The UV5Tof ZM7 and UV5TofZM8 clones showed a 96-and 82-fold inducibility of the luciferase gene product, respectively, and the AA8Tof ZM7 and AA8Tof ZM16 clones showed an 84-and 93-fold inducibility, respectively. These results show that transcription is equally induced in XPD-defective UV5 and wild-type AA8 cells and that there is no transcription defect in this cell line, as reported earlier (31) .
We monitored TAR in the wild-type and XPD-defective cells and found that transcription enhanced the level of recombination only in the AA8 wild-type and not in the XPD-defective UV5 cells ( Figure 1C and D) . Thus, these data show that TAR requires the functional XPD gene product.
We next wanted to test if the recombination defect in UV5 cells could be reverted by introduction of the wild-type human XPD gene product. The wild-type XPD gene was cloned into an expression vector and transfected into UV5TofZM7 cells and individual clones resistant to the selective medium were chosen. The clones were screened for XPD protein expression using a UV survival assay and an NER incision assay. We found that expression of wild-type XPD protein reverts the UV sensitivity in UV5 cells, but not to the same level as found in wild-type AA8 cells (Figure 2A) . Also, we found that NER incision after UV damage was restored after reintroduction of the XPD gene ( Figure 2B ), further supporting that the NER defect is rescued in these cells. Following this, we measured the recombination frequency in XPD-complemented UV5 cells and found that the recombination defect was partially reverted ( Figure 2C ). Interestingly, we also found that background recombination levels were increased following expression of wild-type XPD protein ( Figure 2C ).
XPD-defective cells are functional for DNA DSB-induced HR
We found that XPD-defective UV5 cells show both reduced spontaneous levels of HR as well as a defect in TAR. To test if XPD-defective cells are also defective in DNA DSB-induced HR, we utilised the restriction site for the I-SceI endonuclease present in the 5# neo copy on the recombination reporter ( Figure 1A) . We transiently transfected the cells with the pCMV3xnlsI-SceI vector to induce a DSB and monitored the recombination frequency as reversion to a functional neo R gene, selected with G418. We found similar levels of DSBinduced HR between wild-type, XPD-defective and XPDcomplemented cells (Figure 3A) , showing that there is no general defect in DSB-induced HR present in the XPDdefective UV5 cell line.
In the HR process, the RAD51 protein assembles into nuclear foci, which can be used to score active HR (32) . Here, we analysed the induction of RAD51 foci by immunofluoresence in cells irradiated with c-rays (10 Gy), in order to induce DSBs, or treated with 2 mM thymidine for 24 h. Thymidine is an agent that depletes cells of deoxycytidinetriphosphates, leading to slowing of replication forks and accumulation of cells in the S phase of the cell cycle (33) . The treatment stalls replication forks and triggers HR without the formation of detectable DSBs (34) . Here, we report that the XPD-deficient cell line UV5TofZM7 showed similar levels of c-irradiation-induced RAD51 foci as the wild-type cell line AA8TofZM7 and the reconstituted cell line UV5TofZMX1 ( Figure 3B ), confirming that the XPD protein has no role in DSB-induced HR. Interestingly, the UV5TofZM7 cell line showed a lower level of RAD51 foci formation following thymidine treatment compared to the XPD-proficient cell lines, indicating an increased sensitivity to lesions formed by stalled replication forks.
In addition, we observe that the spontaneous amount of RAD51 foci formed in untreated XPD-defective cells is at the same level as in wild-type or reconstituted cells, which is in conflict with the low HR levels on the recombination substrate found in the cells.
The CSB protein in TAR Above, we find that the XPD protein is involved in TCR is also required for TAR, in agreement with the collision theory between RNAPII and replication forks explaining the increase in HR. Next, we wanted to test whether the RNAPII can sense the oncoming replication fork to initiate TAR in a similar manner as DNA damage is sensed at a transcription block to initiate NER. To test this, we stably transfected the hamster cell line UV61, deficient in the TCR-specific protein CSB (25) , with our TARneo recombination substrate. Two clones were selected based on their ability to induce luciferase. Notably, the UV61 cells had a lower induction of transcription as compared to AA8 or UV5 cells (Figure 4A ), in agreement with a general transcription defect in these cells (13) . The UV61 clones are sensitive to UV irradiation, in concordance with a TCR deficiency, as shown by a clonogenic survival assay following UVC irradiation at varying doses ( Figure 4B ). TAR assays were consequently performed, revealing that the CSB-deficient cells were unable to increase HR when transcription was turned on in the absence of DOX ( Figure 4C) . Notably, the spontaneous HR level was in the same range as for the wildtype cell lines AA8TofZM7 and AA8Tof ZM16, showing that there is no general recombination defect in these cells (data not shown). As the inability to form RAD51 foci after thymidine treatment is linked with a TAR defect (35), we next performed immunofluorescence experiments to investigate the recombination proficiency as measured by RAD51 foci formation. The UV61cell line was proficient in RAD51 foci formation following both c-irradiation and thymidine treatments ( Figure 4D ), which is an uncommon phenotype for TARdefective cells (35) . Furthermore, there seemed to be no general defect in HR in UV61 cells since RAD51 foci efficiently form in UV61 cells.
Discussion
Here, we show a novel role for the XPD protein in catalysing TAR and demonstrate that the TAR defect in XPD-deficient cells can be restored by reintroduction of the functional XPD gene. Since there is no general transcription defect in XPD-defective UV5 and wild-type AA8 cells, our data point to a direct role of the XPD protein in catalysing TAR. Previously, the BRCA2 protein was found to have a role in TAR (35) , which is likely owing to its general role in HR (36) . Interestingly, we observe that XPD has no general defect in HR as cells defective in XPD can efficiently form RAD51 foci after ionising radiation (IR) as well as efficiently repair an ISceI-induced DSB by HR. Thus, we conclude that XPD is specifically involved in TAR.
The UV5 cells have an XPD mutation (C116Y) within the conserved 4Fe-4S cluster, a mutation that has been suggested to give a XP/CS phenotype, although this is unconfirmed at present (37) . Here, we find that UV5 cells do not have a transcription defect, a hallmark of CS (13), suggesting that the C116Y mutation is related to XP. The exact role of the 4Fe-4S cluster in XPD is unknown and deletions within this region decrease the stability of the protein. For instance, the 4Fe-4S cluster mutations, C88S and C102S destabilise the tertiary structure and impair helicase activity, supporting the hypothesis that the cluster is essential for XPD catalytic activity (38) . The recent determination of the XPD crystal structure suggests that the gated channel and position of the 4Fe-4S cluster in XPD are ideal for efficient damage sensing (39) in agreement with previous studies showing reduced TFIIH in cells homozygous for the R112H mutation, which does not affect the XPD interaction with its p44 partner in TFIIH (40) . Thus, it is likely that the XPD C116Y can retain transcriptional activity, while being deficient in DNA damage sensing. Thus, our data link DNA damage sensing in XPD to TAR. Exactly how TAR is activated by XPD remains unknown, but our speculation is that TFIIH is needed to unwind DNA adjacent to a stalled RNA polymerase in order to activate HR.
Interestingly, we found that the spontaneous recombination levels, i.e. in the absence of transcription over the Spontaneous HR levels may vary widely between clones as we do not have any selection against spontaneous neo R revertants in the cell population. This high variation is seen between clones in both AA8 and UV5 cells in this report. Interestingly, the low level of HR in the UV5TofZM7 clone is reverted upon introduction of a functional XPD protein ( Figure 2C ), suggesting that the spontaneous HR levels indeed are lower in UV5 cells. Such reduced spontaneous HR levels are not explained by a general defect in HR, as we show that XPD-defective UV5 cells are proficient in IR and I-SceIinduced HR ( Figure 3) . As UV5 cells are not defective in HR, the reduced levels of spontaneous HR could be due to a large portion of spontaneous HR events being triggered by transcription. Alternatively, XPD may be involved in catalysing HR events induced by means other than following transcription.
Interestingly, we find that UV5 cells are unable to form the same amount of thymidine-induced RAD51 foci as wild-type or XPD-complemented cells. These data corroborate the role of XPD in TAR and suggest that TAR is closely associated with replication fork repair (see ref. 35 for model). Furthermore, these data suggest that the spontaneous HR defect in UV5 cells may be related to a role of spontaneous HR in repair of lesions occurring at replication forks. Previously, it has been shown that spontaneous HR is associated with replication in mammalian cells (41) .
If the XPD protein is involved in catalysing TAR through its damage recognition, there is a possibility that other factors involved in TCR also have a defect in TAR. To test this, we investigated the involvement of the CSB protein in TAR and found a TAR defect. However, since these cells also show a general transcription defect, with a 50% reduction in transcriptional activity compared to wild-type cells, we cannot tell whether the TAR defect in UV61 cells is simply related to a general decrease in transcription or a genuine defect in TAR. Additional reasons for us to query the role of CSB in TAR are as follows: (i) that UV61 cells are able to trigger RAD51 foci in response to thymidine and (ii) that the spontaneous HR levels in UV61 cells remain the same as in wild type, rather than decreasing as in UV5 cells.
In conclusion, we show a novel role for the XPD protein in TAR and report that transcription may be responsible for a portion of the spontaneous recombination events observed in mammalian cells. Future studies should be directed to determine whether a defect in TAR may explain the different clinical features of the XP, TTD and CS patients. 
